/AIRS

AirSculpt Technologies Inc

AIRS

$2.42USD↑+0.83%+0.02 today

MARKET CAP

174.5M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$2 – $2

52W RANGE

$2

$12

AI Summary

Stalk

StalkMedium

In Stage 2 Advancing, AIRS retains a medium-term bullish bias underpinned by higher highs/lows and support at the rising 50 DMA, but short-term timing is neutral as price pulls back into the 9/21/50 EMA zone. Execution should be deferred around this support range, seeking evidence of acceptance before committing. Primary risk is a decisive break below the 50 DMA and prior higher-low, which would invalidate the bullish outlook.

↑Pursuing GLP-1 market, aiming $100M+ revenue from post-treatment aesthetics
↑Same-center cases up 21pp YoY, stabilizing core body-contouring revenue
↓Earnings yield at -1.94% indicates inability to generate shareholder returns

Full analysis →

Buying

3

institutions

Selling

4

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	1.28 M	5.75 M	+474.79 K	+152.9%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUY	470.72 K	2.12 M	+161.39 K	+142.0%	0.00%
MM Millennium Management LLC Q2 2026	BUYNEW	373.32 K	1.68 M	+373.32 K	+0.0%	0.00%
CA Citadel Advisors LLC Q2 2026	SELL	39.00 K	175.50 K	+-122.30 K	-61.5%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	4.03 K	18.23 K	+-1.32 K	+24.8%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	SELL	0.00	0.00	+-2.94 M	-100.0%	0.00%
EP Eversept Partners, LP Q2 2026	SELL	0.00	0.00	+-74.14 K	-100.0%	0.00%